Martín Suárez
Research Assistant
IBD is a chronic inflammatory condition of the gastrointestinal tract that imposes a substantial burden on patients, with prevalence and incidence rising globally, particularly in Western countries. Current therapies for IBD primarily focus on suppressing inflammation; however, a significant proportion of patients either fail to respond or develop resistance over time.
Mucosal healing is now recognized as a critical therapeutic endpoint in the management of IBD, as it is associated with improved clinical outcomes and reduced rates of disease progression. I am analyzing bulk, single-cell and spatial RNA-seq data from IBD patients and models to better characterize and understand mucosal healing.
Villablanca Lab | KI 